Vasoconstrictors that bind to phospholipase C-coupled receptors elevate inositol-1,4,5-trisphosphate (IP 3 ). IP 3 is generally considered to elevate intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in arterial myocytes and induce vasoconstriction via a single mechanism: by activating sarcoplasmic reticulum (SR)-localized IP 3 receptors, leading to intracellular Ca 2ϩ release. We show that IP 3 also stimulates vasoconstriction via a SR Ca 2ϩ release-independent mechanism. In isolated cerebral artery myocytes and arteries in which SR Ca 2ϩ was depleted to abolish Ca 2ϩ release (measured using D1ER, a fluorescence resonance energy transfer-based SR Ca 2ϩ indicator), IP 3 activated 15 pS sarcolemmal cation channels, generated a whole-cell cation current (I Cat ) caused by Na ϩ influx, induced membrane depolarization, elevated [Ca 2ϩ ] i , and stimulated vasoconstriction. The IP 3 -induced I Cat and [Ca 2ϩ ] i elevation were attenuated by cation channel (Gd 3ϩ , 2-APB) and IP 3 receptor (xestospongin C, heparin, 2-APB) blockers. TRPC3 (canonical transient receptor potential 3) channel knockdown with short hairpin RNA and diltiazem and nimodipine, voltage-dependent Ca 2ϩ channel blockers, reduced the SR Ca 2ϩ release-independent, IP 3 -induced [Ca 2ϩ ] i elevation and vasoconstriction. In pressurized arteries, SR Ca 2ϩ depletion did not alter IP 3 -induced constriction at 20 mm Hg but reduced IP 3 -induced constriction by Ϸ39% at 60 mm Hg. [Ca 2ϩ ] i elevations and constrictions induced by endothelin-1, a phospholipase C-coupled receptor agonist, were both attenuated by TRPC3 knockdown and xestospongin C in SR Ca 2ϩ -depleted arteries. In summary, we describe a novel mechanism of IP 3 -induced vasoconstriction that does not occur as a result of SR Ca 2ϩ release but because of IP 3 receptor-dependent I Cat activation that requires TRPC3 channels. The resulting membrane depolarization activates voltage-dependent Ca 2ϩ channels, leading to a myocyte [Ca 2ϩ ] i elevation, and vasoconstriction. (Circ Res. 2008;102:1118-1126.) 
M any vasoconstrictors bind to phospholipase (PL)Ccoupled receptors, leading to an elevation in intracellular diacylglycerol (DAG) and inositol-1,4,5,-trisphosphate (IP 3 ). DAG directly modulates ion channels, including transient receptor potential (TRP) channels, and activates protein kinase (PK)C, which can phosphorylate a wide variety of proteins that regulate arterial myocyte contractility, including ion channels. 1, 2 In contrast, IP 3 binds to IP 3 receptors (IP 3 Rs) located on the sarcoplasmic reticulum (SR), leading to SR Ca 2ϩ release and an increase in myocyte [Ca 2ϩ ] i . 1 The resulting activation of Ca 2ϩ /calmodulin-dependent myosin light chain kinase stimulates vasoconstriction.
The mechanism by which IP 3 regulates arterial contractility is generally well accepted. 1 Indeed, IP 3 -induced SR Ca 2ϩ release is considered to be the only mechanism by which this second messenger regulates arterial diameter. However, the physiological mechanisms by which IP 3 regulates intracellu-lar Ca 2ϩ signaling and arterial diameter are poorly understood, and few studies have directly tested the accepted view. Arterial contractility regulation by IP 3 has primarily been studied by using vasoconstrictors that activate PLC. Because PLC activation elevates both DAG and IP 3 and reduces PIP 2 , mechanisms by which IP 3 specifically modulates arterial [Ca 2ϩ ] i signaling and diameter require additional study.
Here, we investigated IP 3 regulation of ion channel activity, intracellular Ca 2ϩ signaling, and contractility in cerebral artery myocytes and pressurized arteries. We show that IP 3 activates a nonselective cation current (I Cat ) in myocytes and induces vasoconstriction via a mechanism that does not require the release of SR Ca 2ϩ but involves IP 3 R and TRPC3 (canonical transient receptor potential 3) channel activation. IP 3 -induced Na ϩ influx produces membrane depolarization, voltage-dependent Ca 2ϩ channel activation, an [Ca 2ϩ ] i elevation, and vasoconstriction. We also show that TRPC3 channel activation is required for the [Ca 2ϩ ] i elevation and vasoconstriction induced by endothelin (ET)-1, a PLC-coupled receptor agonist, and that IP 3 R activation contributes to these responses in SR Ca 2ϩ -depleted arteries. These data indicate that IP 3 R activation can stimulate vascular contraction through a mechanism that is independent of SR Ca 2ϩ release.
Materials and Methods

Tissue Preparation
Animal procedures used were approved by the Animal Care and Use Committee at the University of Tennessee. Sprague-Dawley rats (200 to 250g) of either sex were euthanized, and the brains were removed. Posterior cerebral, cerebellar, and middle cerebral arteries were harvested and used for all measurements. Myocytes were isolated as previously described, 3 maintained at 4°C, and used for experimentation within 8 hours.
Adenovirus Construction
cDNA encoding D1ER, a fluorescence resonance energy transferbased Ca 2ϩ indicator protein that locates to the endoplasmic reticulum lumen, was kindly provided by Dr R.Y. Tsien (University of California, San Diego). 4 A recombinant adenovirus expressing D1ER (adenD1ER) was constructed, as previously described. 5 DMEM containing adenD1ER was inserted into the lumen of isolated endothelium-denuded cerebral artery segments that were placed in serum-free DMEM supplemented with 1% penicillin/ streptomycin and incubated at 37°C (95% O 2 , 5% CO 2 ) for 4 days before experimentation.
Cytosolic and SR Ca 2؉ Imaging
Cytosolic [Ca 2ϩ ] i was measured in isolated myocytes and endothelium-denuded arterial segments using fura-2. Myocytes were imaged using a charge-coupled device camera (Dage-MTI), and arteries were measured using a photomultiplier tube and Ionwizard software (Ionoptix, Milton, Mass), as previously described. 6,7 D1ER fluorescence was measured in myocytes of endothelium-denuded cerebral artery segments using a CoolSNAPfx charge-coupled device camera (Photometrics) attached to a Nikon TE300 microscope. D1ER was excited with 436Ϯ10 nm light. Emitted light was alternately collected at 480Ϯ20 nm (donor, cyan fluorescent protein) and 535Ϯ15 nm (acceptor, yellow fluorescent protein), and yellow fluorescent protein/cyan fluorescent protein ratios were calculated every 20 seconds using MetaMorph 6.1 (Universal Imaging Corp).
Patch-Clamp Electrophysiology
Membrane currents were measured using the patch-clamp technique (Axopatch 200B, Clampex 8.2). For perforated-patch recordings, pipette solution contained (in mmol/L): 140 CsCl, 3 MgCl 2 , 0.1 EGTA, 10 Hepes, and 10 glucose (pH 7.2). Bath solution for perforated-patch and conventional whole-cell experiments contained (in mmol/L): 140 NaCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 10 Hepes, and 10 glucose (pH 7.4). For conventional whole-cell, pipette solution contained (in mmol/L): 140 CsCl, 10 Hepes, 10 glucose, 5 Mg-ATP, and 5 EGTA (pH 7.2). Caged IP 3 was introduced via the pipette solution, and IP 3 was photoreleased using six 1-ms UV flashes, each applied 3 seconds apart, that were transmitted through the microscope objective (Cairn Research). For inside-out cation channel recordings, the conventional whole-cell bath solution was used as the pipette solution and the whole-cell pipette solution was used as the bath solution (compositions above). For inside-out K Ca channel recordings, bath solution contained (in mmol/L): 140 KCl, 1.6 hydroxyethylethylenediaminetriacetic acid, 1 EGTA, 2 MgCl 2 , 10 Hepes, and free [Ca 2ϩ ] adjusted to 3 mol/L as previously described (pH 7.2). 8 For cell-attached experiments, the pipette solution was the whole-cell bath solution described above and the bath solution contained (in mmol/L): 140 KCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 10 Hepes, and 10 glucose (pH 7.4). Where appropriate, NaCl was substituted with equimolar N-methyl-D-glucamine-Cl. Whole-cell currents were measured by applying 940-ms voltage ramps between Ϫ120 and ϩ20 mV. Single channel currents were measured at a steady voltage of Ϫ60 mV. Single channel activity (NPo) for each condition in each experiment was calculated by analyzing 5 seconds of continuous data by using pClamp 9 (Axon Instruments).
Pressurized Artery Membrane Potential Measurements
The membrane potential of pressurized artery segments was measured as previously described. 7
Pressurized Artery Diameter Measurements
Pressurized artery diameter was measured using an arteriograph, as previously described. 7
Short Hairpin RNA Silencing Vector Construction
Using pRNA-U6.1/Neo as a template, silencing vectors were constructed to express short hairpin (sh)RNA (GenScript Corp, Piscataway, NJ). shRNA expressed by each vector is processed by Dicer to generate siRNA that specifically targets exon 6 in TRPC3 (TRPC3shV) or a scrambled sequence (TRPC3scrm). 9 Expressed DNA sequences were as follows: for TRPC3shV, GTTCATACTTTACTCCTACTA; and for TRPC3scrm, TGAACATCAGTGCTAGGTTAC.
Reverse Permeabilization
Silencing vectors were inserted intracellularly into cerebral artery segments using a reverse permeabilization procedure previously described. 10, 11 Arteries were placed into serum-free DMEM supplemented with 1% penicillin/streptomycin and incubated at 37°C (95% O 2 , 5% CO 2 ) for 4 days.
Western Immunoblot Analysis
Experiments were performed and data quantified as previously described. 7, 8 TRPC3 and TRPC6 channel protein bands were first normalized to actin and relative change in expression calculated as: (TRPC3shV/actin)/(TRPC3scrm/actin).
Statistical Analysis
Data are presented as meansϮSE. Statistical significance was calculated by using Student's t tests for paired or unpaired data or ANOVA, followed by Student-Newman-Keuls test for multiple comparisons. PϽ0.05 was considered significant.
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Results
IP 3 Elevates [Ca 2؉ ] i in Myocytes With Intact and Depleted SR Ca 2؉
In isolated myocytes, from a resting [Ca 2ϩ ] i of 114Ϯ7 nmol/L, Bt-IP 3 (10 mol/L), a membrane-permeant IP 3 analog, caused a sustained, mean [Ca 2ϩ ] i elevation of Ϸ111 nmol/L ( Figure 1A Because IP 3 is generally considered to elevate myocyte [Ca 2ϩ ] i by mobilizing SR Ca 2ϩ , we studied the contribution of SR Ca 2ϩ release to IP 3 -induced [Ca 2ϩ ] i elevations. Thapsigargin (100 nmol/L), a SR Ca 2ϩ -ATPase blocker, or a combina-tion of thapsigargin (1 mol/L) plus caffeine (10 mmol/L), a ryanodine receptor channel activator, reduced Bt-IP 3 -induced [Ca 2ϩ ] i elevations by Ϸ25% ( Figure 1A ). In contrast, Bt-IP 3 (10 mol/L) did not change [Ca 2ϩ ] i when applied in the absence of extracellular Ca 2ϩ in thapsigargin-pretreated (100 nmol/L; Ͼ15 minutes) myocytes ( Figure 1B ). In the presence of Bt-IP 3 (10 mol/L) plus thapsigargin (100 nmol/L), CCCP (1 mol/L), a protonophore that depolarizes mitochondria, 6, 12 further increased [Ca 2ϩ ] i by 45Ϯ6 nmol/L (nϭ7, PϽ0.05), indicating that mitochondria attenuate rather than contribute to the IP 3 -induced [Ca 2ϩ ] i elevation. L-Bt-IP 3 , a membrane permeant weak IP 3 R agonist, did not alter [Ca 2ϩ ] i ( Figure 1B) . These data suggest that IP 3 elevates [Ca 2ϩ ] i in arterial myocytes through a SR Ca 2ϩ release-independent mechanism that requires plasma membrane Ca 2ϩ influx.
Thapsigargin (100 nmol/L) caused a transient [Ca 2ϩ ] i elevation of 45Ϯ5 nmol/L, which declined to a steady-state elevation of 6Ϯ3 nmol/L over prethapsigargin [Ca 2ϩ ] i in 14.0Ϯ1.5 minutes (nϭ7, Figure 1B , PϽ0.05 for each). An elevation in thapsigargin concentration from 100 nmol/L to 1 mol/L did not further change [Ca 2ϩ ] i , consistent with 100 nmol/L thapsigargin causing SR Ca 2ϩ depletion ( Figure 1A , nϭ7, PϾ0.05). In agreement, thapsigargin (100 nmol/L to 1 mol/L) abolished caffeine-induced (10 mmol/L) [Ca 2ϩ ] i transients ( Figure 1A and Figure I in the online data supplement).
To determine whether IP 3 elevated [Ca 2ϩ ] i by releasing a Ca 2ϩ store that was not depleted by SR Ca 2ϩ -ATPase inhibition or ryanodine receptor channel activation, we measured [Ca 2ϩ ] within the entire SR using D1ER, a fluorescence resonance energy transfer-based Ca 2ϩ indicator that targets to the endoplasmic reticulum lumen. 4 This methodology also provides a time course of SR Ca 2ϩ depletion. Thapsigargin (100 nmol/L) reduced D1ER mean fluorescence ratio to a plateau of 0.87Ϯ0.04 within 15 minutes, consistent with a reduction in SR Ca 2ϩ concentration ([Ca 2ϩ ] SR , nϭ6, PϽ0.05, Figure 2 ). Coapplication of Bt-IP 3 (10 mol/L) with thapsigargin (100 nmol/L), or an elevation in thapsigargin concentration to 5 mol/L, did not further change D1ER ratio (to 0.88Ϯ0.04 and 0.85Ϯ0.04, respectively, PϾ0.05 for each, nϭ6, Figure 2 ). Collectively, these data indicate that, in cerebral artery myocytes, a 15-minute application of 100 nmol/L thapsigargin depletes Ca 2ϩ in the entire SR; that IP 3 does not further reduce [Ca 2ϩ ] SR when applied in the presence of 100 nmol/L thapsigargin; and that IP 3 elevates [Ca 2ϩ ] i in arterial myocytes via a SR Ca 2ϩ release-independent mechanism.
IP 3 Activates a I Cat in Myocytes With Intact and Depleted SR Ca 2؉
To investigate mechanisms by which IP 3 elevates [Ca 2ϩ ] i in myocytes, we measured plasma membrane I Cat . When using the perforated patch-clamp configuration, Bt-IP 3 (10 mol/L) increased mean whole-cell I Cat amplitude from Ϸ28 to 120 pA, or Ϸ4.3-fold at Ϫ120 mV ( Figure 3B ). Bt-IP 3 similarly activated I Cat when applied to myocytes pretreated with thapsigargin ( Figure 3A and 3B ). I Cat regulation by IP 3 or photolytic release of intracellular caged IP 3 (both introduced via the pipette solution) was also studied in thapsigargintreated myocytes by using the conventional whole-cell configuration, with [Ca 2ϩ ] i strongly buffered using EGTA. IP 3 and release of caged IP 3 increased I Cat Ϸ2.6to 3.4-fold ( Figure 3B ). Gd 3ϩ reversed I Cat activation by Bt-IP 3 and caged IP 3 ( Figure 3B ). In contrast, thapsigargin (100 nmol/L to 5 mol/L) did not alter I Cat ( Figure 3B ). These data indicate that IP 3 activates a I Cat in myocytes with either intact or depleted SR Ca 2ϩ .
The cell-attached and excised inside-out patch-clamp configurations were used to study IP 3 -activated single channel currents in myocytes with depleted SR Ca 2ϩ (100 nmol/L thapsigargin; Ͼ15 minutes). In 8 of 9 cell-attached patches at Ϫ60 mV, Bt-IP 3 increased the mean activity (NPo) of 0.91Ϯ0.13 pA single channels from 0.10Ϯ0.02 to 0.75Ϯ0.22 ( Figure 3C ). In inside-out patch-clamp experiments, we ensured that the internal membrane surface was accessible to the bath solution by confirming that K Ca channels observed in a K ϩ -containing bath solution were inhibited on switching to the CsCl-containing bath solution used to measure cation channels. In inside-out membrane patches at Ϫ60 mV, IP 3 (20 mol/L, nϭ27), oleoyl acetyl glycerol (OAG) (10 mol/L, nϭ8), or IP 3 (20 mol/L) plus OAG (10 mol/L, nϭ8) did not activate single channels. Therefore, these data suggest that an intact myocyte is required for IP 3 -induced cation channel activation.
We next investigated mechanisms mediating IP 3 -induced I Cat activation. Xestospongin C (XeC), a membrane permeant IP 3 R blocker, and heparin, an impermeant IP 3 R inhibitor (1 mg/mL), reduced mean IP 3 -induced I Cat in SR Ca 2ϩ -depleted myocytes from Ϸ95 to Ϸ32 and 18 pA, respectively ( Figure  3B) . A reduction in extracellular Na ϩ from 140 to 20 mmol/L also reduced mean IP 3 -induced I Cat to Ϸ33 pA ( Figure 3B ). These data indicate that IP 3 R activation is required for IP 3 -induced I Cat activation and that Na ϩ is the principal cation generating I Cat .
IP 3 Depolarizes and Constricts Pressurized Arteries With Intact and Depleted SR Ca 2؉
Physiological functions of IP 3 -induced I Cat activation were studied by measuring membrane potential and diameter regulation of pressurized endothelium-denuded arteries. Arteries were studied primarily at low intravascular pressure (20 mm Hg) to: (1) improve success of sustained microelectrode impalement by reducing vasomotion; (2) maintain a relatively negative membrane potential, which creates a larger driving force for cation influx; and (3) reduce negativefeedback regulation of membrane potential and diameter by Ca 2ϩ sparks and K Ca channels. 3, 13, 14 At 20 mm Hg, Bt-IP 3 depolarized SR Ca 2ϩ -depleted arteries by Ϸ16 mV ( Figure  4A and 4B) . At 20 mm Hg, Bt-IP 3 also reduced the diameter of pressurized arteries with intact SR Ca 2ϩ by Ϸ12 m, from a mean diameter of 142Ϯ9 m ( Figure 5C ). At 20 mm Hg, thapsigargin (100 nmol/L to 3 mol/L) did not change diameter and did not reduce Bt-IP 3 -induced vasoconstriction ( Figure 5A and 5C ). Nimodipine, a voltage-dependent Ca 2ϩ channel blocker, reduced Bt-IP 3 -induced constriction by Ϸ83% ( Figure 5B and 5C ). At 60 mm Hg, Bt-IP 3 reduced the diameter of arteries with intact SR Ca 2ϩ by Ϸ11 m ( Figure  5D ). At 60 mm Hg, thapsigargin (100 nmol/L) reduced diameter by Ϸ12 m and attenuated the Bt-IP 3 -induced constriction by Ϸ39% ( Figure 5D ). These data indicate that SR Ca 2ϩ release is not required for IP 3 -induced vasoconstriction, IP 3 constricts via voltage-dependent Ca 2ϩ channel acti- vation, and diameter regulation by IP 3 -induced SR Ca 2ϩ release and SR Ca 2ϩ depletion are both pressure-dependent.
TRPC3 Channels Are Required for IP 3 -Induced [Ca 2؉ ] i Elevation and Vasoconstriction
Silencing vectors were constructed that express either shRNA targeting TRPC3 exon 6 (TRPC3shV) or scrambled shRNA (TRPC3scrm). Western blot analysis indicated that TRPC3shV reduced TRPC3 channel protein to Ϸ34% of TRPC3scrm ( Figure 6A and 6B) . In contrast, TRPC3shV did not alter TRPC6 channel expression in the same arteries ( Figure 6A and 6B).
[Ca 2ϩ ] i was measured in SR Ca 2ϩ -depleted myocytes that were isolated from arteries treated with TRPC3shV or TRPC3scrm vectors. TRPC3 knockdown did not alter resting [Ca 2ϩ ] i (TRPC3scrm, 113Ϯ4 nmol/L, nϭ14; TRPC3shV, 116Ϯ3 nmol/L, nϭ19, PϾ0.05). However, mean Bt-IP 3induced [Ca 2ϩ ] i elevations in TRPC3shV-treated myocytes were Ϸ18% of those in TRPC3scrm-treated myocytes (Figure 6C and 6D ). In addition, Bt-IP 3 -induced constrictions in SR Ca 2ϩ -depleted, pressurized (20 mm Hg), endotheliumdenuded, TRPC3shV-treated arteries were Ϸ29% of those in TRPC3scrm-treated arteries ( Figure 7A through 7C) . Collectively, these data indicate that TRPC3 channel activation contributes to the SR Ca 2ϩ release-independent [Ca 2ϩ ] i elevation and vasoconstriction induced by IP 3 .
ET-1 Elevates [Ca 2؉ ] i and Induces Vasoconstriction Independently of SR Ca 2؉ Release and via IP 3 R and TRPC3 Channel Activation
To investigate functional modulation of cerebral artery Ca 2ϩ signaling and diameter by IP 3 Rs, we studied responses to ET-1, a vasoconstrictor that binds to myocyte PLC-coupled receptors, in endothelium-denuded arteries. 15 ET-1 similarly elevated [Ca 2ϩ ] i when applied to nonpressurized control arteries or arteries with depleted SR Ca 2ϩ ( Figure 8B ). In SR Ca 2ϩ -depleted arteries, XeC did not alter [Ca 2ϩ ] i when applied alone (3Ϯ6 nmol/L change, nϭ5, PϽ0.05) but reduced mean ET-1-induced [Ca 2ϩ ] i elevation by Ϸ73% ( Figure 8A and 8B). TRPC3 knockdown also reduced mean ET-1-induced [Ca 2ϩ ] i elevation to Ϸ32% of that in TRPC3scrm-treated arteries ( Figure 8B ). In agreement with the [Ca 2ϩ ] i responses, ET-1 similarly constricted pressurized (20 mm Hg) arteries with intact or depleted SR Ca 2ϩ (Figure 8C and 8D) . XeC also reduced ET-1-induced vasoconstriction in arteries with depleted SR Ca 2ϩ by Ϸ53% ( Figure 8C and 8D ). In addition, TRPC3 knockdown reduced mean ET-1-induced constriction in pressurized (20 mm Hg) arteries to Ϸ55% of that in TRPC3scrm-treated arteries ( Figure 8D ). These data indicate that TRPC3 channel activation is necessary for ET-1 to elevate [Ca 2ϩ ] i and induce vasoconstriction in cerebral arteries and that IP 3 R activation contributes to the SR Ca 2ϩ release-independent responses.
Discussion
It is generally well accepted that IP 3 contracts arterial myocytes by stimulating SR Ca 2ϩ release. Here, we provide an additional mechanism by which IP 3 regulates arterial contractility. In arterial myocytes, a transient or sustained IP 3 elevation activates a I Cat that occurs primarily because of Na ϩ influx. Importantly, activation of this contractile mechanism by IP 3 does not require the stimulation of SR Ca 2ϩ release. We also show that the SR Ca 2ϩ release-independent, IP 3 -induced [Ca 2ϩ ] i elevation and vasoconstriction require IP 3 R, TRPC3 channel, and voltage-dependent Ca 2ϩ channel activation. These data indicate that IP 3 R activation stimulates a I Cat to which TRPC3 channels contribute, leading to membrane depolarization, voltage-dependent Ca 2ϩ channel activation, an [Ca 2ϩ ] i elevation, and vasoconstriction. These findings reveal a novel physiological signaling pathway for IP 3 in the vasculature.
To study IP 3 regulation of myocyte I Cat , [Ca 2ϩ ] i , and contractility through SR Ca 2ϩ release-independent mechanisms, SR Ca 2ϩ was depleted using thapsigargin. A concentration of 100 nmol/L thapsigargin abolished caffeineinduced [Ca 2ϩ ] i transients, indicating that SR containing ryanodine receptor channels was Ca 2ϩ -depleted. We also used D1ER to measure [Ca 2ϩ ] in the entire SR and to obtain a time course of the thapsigargin-induced reduction in [Ca 2ϩ ] SR . Data indicated that a 15-minute application of 100 nmol/L thapsigargin depleted SR Ca 2ϩ . D1ER measurements also indicated that when IP 3 was applied with thapsigargin, the I Cat activation, [Ca 2ϩ ] i elevation, and vasoconstriction did not occur as a result of a further change in [Ca 2ϩ ] SR . In addition, in conventional whole-cell experiments, IP 3 activated a I Cat in myocytes that were exposed to thapsigargin and internally perfused with a pipette solution containing 5 mmol/L EGTA, which would deplete Ca 2ϩ in all SR compartments. Collectively, these data indicate that IP 3 activates a I Cat via a SR Ca 2ϩ release-independent mechanism.
Store-operated cation currents have been reported in myocytes from several vessels, including mesenteric artery, portal vein, and aorta. 16 The regulation, ion selectivity, and conductance of myocyte store-operated cation currents vary depending on the anatomic origin of the vasculature. 16 In the present study, thapsigargin (100 nmol/L to 5 mol/L) did not activate a myocyte I Cat and did not alter the diameter of arteries pressurized to 20 mm Hg but constricted arteries pressurized to 60 mm Hg. These data indicate that cerebral artery diameter regulation by SR Ca 2ϩ depletion is pressure-dependent. These data are also consistent with previous evidence that SR Ca 2ϩ depletion constricts cerebral arteries by inhibiting Ca 2ϩ sparks and K Ca channels, which are activated by an elevation in intravascular pressure. 3, 13, [17] [18] [19] In nonpressurized rabbit and rat cerebral arteries, store depletion also did not induce depolarization and caused an [Ca 2ϩ ] i elevation that did not stimulate contraction. 20, 21 Here, thapsigargin caused a myocyte [Ca 2ϩ ] i transient that declined to a steady-state [Ca 2ϩ ] i elevation of Ϸ6 nmol/L. Consistent with these findings, SR Ca 2ϩ -ATPase inhibition also likely elevates cytosolic [Ca 2ϩ ] i by removing a SR Ca 2ϩ sink. In contrast, in myocytes of rabbit pial arteriole fragments and murine cerebral artery myocytes, SR Ca 2ϩ depletion activated an inward current. 22, 23 Different findings of these studies may be attributable to experimental approach, species, vessel size, and anatomic origin. However, it is unclear why in the present study the thapsigargin-induced [Ca 2ϩ ] i transient did not cause an associated transient vasoconstriction in pressurized arteries. Conceivably, this may occur because of Ca 2ϩ compartmentaliza-tion in a noncontractile location that can activate CREB, as previously proposed. 20, 24 At 20 mm Hg, SR Ca 2ϩ depletion did not alter IP 3 or ET-1-induced vasoconstriction. In contrast, at 60 mm Hg, SR Ca 2ϩ depletion reduced IP 3 -induced vasoconstriction by Ϸ39%. These data indicate that vasoregulation by IP 3 is pressure-dependent. In addition, findings indicate that over this pressure range, IP 3 R activation promotes vasoconstriction primarily by activating a I Cat , which is contrary to the conventional view of IP 3 -induced vasoconstriction. The increasing contribution of SR Ca 2ϩ release to the IP 3 -induced vasoconstriction likely occurs because pressure-induced arterial depolarization activates voltage-dependent Ca 2ϩ channels, which elevates cytosolic [Ca 2ϩ ] i and [Ca 2ϩ ] SR . Thus, data suggest that arterial depolarization increases the contribution of SR Ca 2ϩ release to the IP 3 -induced [Ca 2ϩ ] i elevation and vasoconstriction. In isolated myocytes, SR Ca 2ϩ depletion reduced the IP 3 -induced [Ca 2ϩ ] i elevation by Ϸ25%. An explanation for this result is that isolated myocytes are more depolarized than myocytes in arteries at low pressure. Thus, isolated myocytes have a higher [Ca 2ϩ ] SR and IP 3 -induced SR Ca 2ϩ release contributes to the [Ca 2ϩ ] i elevation. IP 3 , photoreleased IP 3 , and membrane permeant IP 3 all activated a I Cat in arterial myocytes via a mechanism that did not require the stimulation of SR Ca 2ϩ release. I Cat activation by IP 3 was blocked by IP 3 R inhibitors, cation channel blockers, and a reduction in extracellular Na ϩ . In intact myocytes, IP 3 activated 15 pS (0.91 pA at Ϫ60 mV) single channels. Our data suggest that, in cerebral artery myocytes, IP 3 does not directly activate cation channels, and that DAG does not act as a cofactor for activation. In intact cerebral artery myocytes, DAG stimulates cation channels via PKC activation. 25 The lack of effect of OAG in inside-out patches suggests that activated PKC translocates from the cytosol to the membrane to stimulate cation channels. These data indicate that IP 3 R activation mediates IP 3 -induced I Cat activation. In contrast, in rabbit portal vein myocyte excised patches, IP 3 activated 2 pS Ca 2ϩ -selective channels. 26 In rabbit coronary artery myocytes, IP 3 only activated Ca 2ϩselective channels if patches were also exposed to OAG. 27 Variability in I Cat regulation by PLC products or SR Ca 2ϩ depletion in myocytes of anatomically diverse arteries may occur because of cell type-specific TRP channel expression or heteromultimer formation. 16, 28 Vascular myocytes express at least 4 TRP families: TRPC (canonical TRP), TRPM (melastatin TRP), TRPV (vanilloid TRP), and TRPP (polycystin TRP). 29 -32 Rat cerebral artery myocytes express several TRP channels, including TRPC1, -3, -4, and -6 and TRPM4 and TRPV4. 10, 21, 29, 33, 34 Although TRPC3 channels are Na ϩ -and Ca 2ϩ -permeant (P Na :P Ca ϭ1:1.5), Na ϩ influx would be predominant with physiological extracellular cation gradients, consistent with observations made here. 2, 35 The IP 3 -activated channels described here are also similar in conductance to TRPC3 channels. 28 We show that TRPC3 channel knockdown attenuates both the ET-1-and IP 3induced [Ca 2ϩ ] i elevation in myocytes and vasoconstriction in pressurized arteries. Whether the IP 3 R-activated channels in myocytes are formed from homomultimers or heteromultimers containing TRPC3 remains to be resolved, particularly because vascular myocyte heteromultimeric TRPC channels have been described. 36 In cerebral artery myocytes, UTP, another PLC-coupled receptor agonist, activates TRPC3 channels but the mechanisms mediating this effect are unclear. 34 Here, XeC reduced both the ET-1-induced [Ca 2ϩ ] i elevation and the constriction in SR Ca 2ϩ -depleted arteries. Voltage-dependent Ca 2ϩ channel blockers also robustly reduced the IP 3 -induced [Ca 2ϩ ] i elevation and vasoconstriction. Thus, data suggest that IP 3 is one second messenger mediating vasoconstrictor-induced I Cat activation, IP 3 R activation mediates this response, and IP 3 -induced Ca 2ϩ influx occurs primarily through depolarization-induced, voltage-dependent Ca 2ϩ channel activation.
A major finding of the present study is that IP 3 constricted arteries not by stimulation of SR Ca 2ϩ release but by a mechanism which required IP 3 R and TRPC3 channel activation. Although the molecular mechanism mediating IP 3induced I Cat activation was not determined, conformational coupling between IP 3 Rs and TRP channels regulates plasma membrane cation influx. 37, 38 Indeed, IP 3 Rs interact molecularly with many TRPC channel isoforms, including TRPC3. 28 In HEK293 cells, IP 3 -induced TRPC3 channel activation required IP 3 Rs but did not require endoplasmic reticulum Ca 2ϩ release. 39 Similarly, in DT40 cells IP 3 recognition by nonconducting IP 3 Rs activated plasma membrane cation in-flux. 40 Thus, physical coupling between IP 3 Rs and TRP channels may mediate vasoregulation by IP 3 .
In summary, we describe a novel mechanism of IP 3induced vasoconstriction that requires IP 3 R activation but not the stimulation of SR Ca 2ϩ release. We show that IP 3 R activation by IP 3 stimulates a I Cat . The resulting Na ϩ influx induces membrane depolarization, leading to voltagedependent Ca 2ϩ channel activation, an [Ca 2ϩ ] i elevation, and vasoconstriction. We also show that TRPC3 channel activation contributes to the IP 3 -induced [Ca 2ϩ ] i elevation and vasoconstriction. These findings supplement the conventional view that IP 3 regulates arterial diameter only by stimulating SR Ca 2ϩ release.
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